Chris sent a Morning Invest Facebook video titled “Big Pharma is TERRIFIED that you'll learn this about Red Light Therapy.” The guest, Jonathan Otto, argues that red light therapy can help acne, pain, depression, eyesight, hair loss, thyroid disease, long COVID and cancer — then promotes his own red-light products. The clean read is: photobiomodulation is real science, but this video turns it into a near-universal product pitch.

Medical caution
This is source review and health-media literacy, not medical advice, cancer treatment guidance, eye-treatment guidance, thyroid-medication guidance or a recommendation to buy a device. Do not replace cancer care, eye care, thyroid medication, depression care or long-COVID care with a video or consumer panel.
What the video claims
The video frames red light therapy as a natural curative that the medical/pharmaceutical world is resisting. It discusses acne, arthritis, inflammation, sleep, energy, recovery, depression, fibromyalgia, eyesight, hair loss, thyroid disease, long COVID and multiple cancer claims. Near the end, the guest states that myredlight.com is his company and provides discount codes, making this both education and product marketing.
What is real
Photobiomodulation, also called low-level light therapy, is a real research field. There are studies and reviews for pain, fibromyalgia, hair loss, mood symptoms, skin conditions, myopia control and other uses. Effects depend on the condition, wavelength, dose, device, body site, trial quality and patient selection.
Photodynamic therapy is also real cancer medicine. But it is a different category: it uses a photosensitizing drug plus carefully delivered light to damage targeted cells. The NCI describes photodynamic therapy as a treatment that uses a drug activated by light. That is not the same thing as standing in front of a home red-light panel.
Where the video overreaches
The prostate-cancer section appears to refer to vascular-targeted photodynamic/phototherapy studies in low-risk prostate cancer. Those are clinician-delivered cancer procedures involving a photosensitizer and targeted treatment — not proof that consumer panels replace chemotherapy, radiotherapy, surgery or oncology care.
The eyesight section is especially risky. The video suggests people may get “complete reversal” if they repeatedly use red light. There is real research on repeated low-level red-light therapy for pediatric myopia and some small studies on aging vision, but eye exposure should be medical/device-specific, not improvised from a Facebook interview.
The thyroid, long-COVID, depression, cancer and “detoxifying cells” claims are too broad. Some early or small studies exist in parts of these areas, but the video’s certainty outruns the evidence and repeatedly leans on anecdotes.
Evidence labels
- Verified: The video exists, is by Morning Invest, and promotes red light therapy as a suppressed natural therapy.
- Verified: The guest promotes his own red-light company and discount codes.
- Real science: Photobiomodulation and photodynamic therapy are real, studied light-based medical/biological approaches.
- Critical distinction: Photodynamic cancer therapy with a photosensitizer is not the same as consumer red-light panels.
- Some evidence, condition-specific: hair loss, pain/fibromyalgia, depressive symptoms and pediatric myopia have clinical literature, but results vary.
- Overstated: claims of cancer substitution, complete eyesight reversal, thyroid-medication replacement, long-COVID remission, broad organ stimulation and Big Pharma suppression.
Primary links
- Facebook video: Morning Invest red light therapy interview
- NCI: Photodynamic Therapy to Treat Cancer
- PubMed: vascular targeted phototherapy vs active surveillance for low-risk prostate cancer
- PubMed: umbrella review of photobiomodulation RCTs
- PubMed: low-level laser therapy for fibromyalgia review/meta-analysis
- PubMed: photobiomodulation for depressive symptoms systematic review/meta-analysis
- PubMed: repeated low-level red-light therapy for pediatric myopia review/meta-analysis
- PubMed: low-level laser therapy plus minoxidil for androgenetic alopecia review
- PubMed: low-level laser therapy in chronic autoimmune thyroiditis RCT
- FDA: laser products and instruments
- Local source note and transcript
Bottom line
Red light therapy is not nonsense. But this video mixes legitimate photobiomodulation research, clinical photodynamic cancer procedures, anecdotes, anti-pharma rhetoric and a product pitch. The correct expectation is: real light-based science, condition-specific evidence, and major caution before treating consumer panels as cure-all medicine.
Health Papers, Studies & Films
Continue the source library for health claims, device claims, studies and controversial medical media.
Back to Health Section